Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.

Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.

Bevacizumab treatment can result in tumor shrinkage of progressive vestibular schwannomas in some neurofibromatosis 2 (NF2) patients but its effect on meningiomas has not been defined. To determine the clinical activity of bevacizumab against NF2-related meningiomas, we measured changes in volume of...

Full description

Bibliographic Details
Main Authors: Fabio P Nunes, Vanessa L Merker, Dominique Jennings, Paul A Caruso, Emmanuelle di Tomaso, Alona Muzikansky, Fred G Barker, Anat Stemmer-Rachamimov, Scott R Plotkin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23555840/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23555840/?tool=EBI

Similar Items